Search

Does the patient with myelofibrosis feel better through Pacritinib?

Pacritinib is an oral next-generation multikinase inhibitor with specificity for JAK2 and FLT3 being evaluated to treat myelofibrosis in two Phase 3 trials.

Read more

Splenic marginal zone lymphoma study update, February 2024

A project update from Dr Ahmed Ludvigsen Al-Mashhadi. I am truly grateful for this opportunity provided by EHA, and for EHA's effort in advancing research in a field that may otherwise be very difficult to explore.

Read more

Poster presentation instructions

Poster Presentations will be presented as a paper poster in Madrid, as well as uploaded as an e-poster in the Congress platform.

Read more

National societies

EHA pursues close collaboration with the national hematology societies to ensure that the professional hematology community in Europe is served in the best possible way.

Read more

What an EHA Research Grant supports

Our EHA Research Grants support basic and translational lab-based research in hematology.

Read more

What an EHA Bilateral Collaborative Grant supports

Our EHA Bilateral Collaborative Grant supports basic and translational lab-based research in hematology. To reflect the collaborative spirit of the grant, the budget must be divided 50:50 between the two PIs.

Read more

General Information

June 1, 2024
EHA2024 Congress platform opens

June 13-16, 2024
EHA2024 Madrid, Spain - In-person and live stream

Location 
IFEMA MADRID RECINTO FERIAL (Fairgrounds), Madrid, Spain

August 15, 2024
EHA2024 Congress platform closes

 
 

Scientific Program Committee (SPC) Chair
Prof Brian Huntly

Official Language
English  

EHA Congress Secretariat
INTERPLAN Congress, Meeting & Event Management…

Read more

SWG Educational Activities

General meetings in 2023Meetings to discuss the progress and management of collaborations within the European networks.

Read more